[1] |
Fazhu FEI,Jiajun LU,Shuai ZHANG,Hao LI,Bin REN.
Clinical application progress of immunization and targeted therapy for Hepatocellular Carcinoma in special populations
[J]. The Journal of Practical Medicine, 2024, 40(6): 738-742.
|
[2] |
Zhipeng WU,Yuqin ZHANG,Minggang WANG,Rongzhen ZHANG,Dewen. MAO.
Expression and biological function of TRP signaling pathway in hepatocellular carcinoma
[J]. The Journal of Practical Medicine, 2024, 40(6): 743-747.
|
[3] |
Yuxin CHENG,Liang LIU,Shiyu DONG,Shengchao LI,Meng ZHANG.
Research advances in exosomal proteins, mRNA and non⁃coding RNA regulation of Hepatocellular Carcinoma
[J]. The Journal of Practical Medicine, 2024, 40(6): 748-755.
|
[4] |
Junhong XU,Hongbing YAO,Xueyao WANG,Wei GUO,Caijin LU,Jiaxing WU,Jianhui JIANG,Dongkang ZHAO.
Clinical efficacy of FOLFOX⁃HAIC combined with lenvatinib and PD⁃1 inhibitor in the treatment of intermediate and advanced Hepatocellular Carcinoma
[J]. The Journal of Practical Medicine, 2024, 40(6): 762-767.
|
[5] |
Lu YAN,Tianwei SHI.
Expression of nicastrin, N1ICD and hes1 proteins in normal and cancerous liver tissues of mice
[J]. The Journal of Practical Medicine, 2024, 40(6): 768-772.
|
[6] |
Renling YAO,Yixuan ZHU,Rui HUANG,Jie LI.
The association between vitamin intake and the progression of metabolic dysfunction⁃associated fatty liver disease
[J]. The Journal of Practical Medicine, 2024, 40(6): 820-826.
|
[7] |
Juan TANG,Yi LI,Liqiong ZHAI,Shaowen LIU,Yong SHEN,Shuo CONG,Yongmei. LIU.
The diagnostic value of miR⁃571 levels in blood from the peripherals in liver fibrosis
[J]. The Journal of Practical Medicine, 2024, 40(5): 653-657.
|
[8] |
Hang DENG,Hao. ZHANG.
Clinical application of hepatocellular carcinoma prediction models: current challenges and future directions
[J]. The Journal of Practical Medicine, 2024, 40(24): 3561-3567.
|
[9] |
Yi WANG,Shuo HE,Siyun YANG,Jun. ZHANG.
In vitro study of 5⁃FU combined with rhCYGB in treating hypoxia⁃induced chemotherapy resistance of hepatocellular carcinoma
[J]. The Journal of Practical Medicine, 2024, 40(22): 3146-3154.
|
[10] |
Yingyuan ZHANG,Chunyan MOU,Danqing XU,Yuanzhen WANG,Lixian CHANG,Chunyun LIU,Weikun LI,Hongyan WEI,Li LIU.
Comparison of clinical efficacy of TMF and TDF in the treatment of hepatitis B liver fibrosis
[J]. The Journal of Practical Medicine, 2024, 40(22): 3215-3220.
|
[11] |
Hua WANG,Yue HEI,Miao SUN,Yanchuang SUN,Juan HAN,Juanhua. SUN.
Efficacy of bevacizumab combined with raltitrexed in the treatment of unresectable hepatocellular carcinoma and its influence on adverse reactions and survival rate
[J]. The Journal of Practical Medicine, 2024, 40(21): 3061-3066.
|
[12] |
Jin LU,Ming WEN,Qingrong TANG,Chunhua XU,Chunling ZHAN,Yizhou XU,Lihui. YANG.
The relationship between the expression of serum GP3 and CHI3L1 and the degree of liver fibrosis and pathological changes in patients with hepatitis
[J]. The Journal of Practical Medicine, 2024, 40(11): 1586-1591.
|
[13] |
WU Linghong, ZHOU Min, LU Yao, ZHU Guangwei..
Value of neutrophil/lymphocyte ratio and its variation value in predicting risk of acute liver function deteri⁃ oration after interventional treatment of hepatocellular carcinoma
[J]. The Journal of Practical Medicine, 2023, 39(6): 713-719.
|
[14] |
ZHAN Yi, NI Caifang, ZHONG Binyan, TIAN Pengcheng..
Research advances of ALBI grade for liver function assessment and prognosis stratification
[J]. The Journal of Practical Medicine, 2023, 39(3): 381-385.
|
[15] |
Yan LIU,Donghua ZHANG,Yuqian HUANG,Youshun LIU,Ji. HUANG.
Inhibitory effect of pristimerin on diethylnitrosamine⁃induced hepatocellular carcinoma in rats by regulating ROS/ASK1/JNK signal pathway
[J]. The Journal of Practical Medicine, 2023, 39(20): 2597-2602.
|